Alternatives to Biogen
Biogen is a Biotech tool: global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Biogen
- Website
Ipsen33BiotechParis, FranceGlobal biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
- Website
Tahoe Therapeutics36BiotechSan Mateo, United States$31.5MDeveloping novel therapies for neurological disorders.
- Website
Anamnesis Bio42Biotechתל אביב - יפו, IsraelDeveloping novel therapeutics for neurodegenerative diseases using advanced biological insights.
- Website
Eli Lilly and CompanyBiotechIndianapolis, United StatesGlobal pharmaceutical company focused on developing and manufacturing medicines.
- Website
Davinci Neuroscience44Life SciencesSan Francisco, United StatesDeveloping a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.
- Website
Prophet Bio34Life SciencesCambridge, United StatesProphet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.
- Website
Pfizer19BiotechnologyNew York City, United StatesA global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.
- Website
SobiOslo, NorwaySobi is a specialized international biopharmaceutical company focused on developing innovative therapies for rare diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Rezolute52BiotechRedwood City, United States$220.0MBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website
Dren Bio48BiotechSan Carlos, United States$156.0MBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
- Website
Alto Neuroscience43BiotechLos Altos, United States$370.0MAlto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Showing the 20 closest matches. See the rest on the Biogen profile.
Compare Biogen head to head
Side by side on what each one does, what it costs, and what real users report.